SAC Capital Advisors, Insider Trading, New York 2013

SAC Capital Advisors, L.P., a hedge fund, and its subsidiaries have been hit with a massive insider trading case in New York. The charges, filed by the U.S. government, claim that the company engaged in a widespread scheme to trade on inside information from 1999 to 2013.

The indictment alleges that the company’s employees, including portfolio managers and analysts, used non-public information to trade in the securities of several publicly traded companies. The trades resulted in significant profits for the company and its employees.

According to the indictment, the trades were made in the securities of companies such as Elan Pharmaceuticals, Wyeth, and Dell Inc. The trades were made based on inside information that included details about upcoming mergers and acquisitions, product launches, and other corporate events.

The indictment also alleges that the company’s employees used various methods to obtain the inside information, including using confidential sources and exploiting relationships with corporate insiders.

The charges against SAC Capital Advisors and its subsidiaries include conspiracy to commit securities fraud, securities fraud, and aiding and abetting securities fraud. The company’s employees also face charges of conspiracy to commit securities fraud and securities fraud.

The case against SAC Capital Advisors and its subsidiaries is the result of a lengthy investigation by the U.S. government, which included a review of millions of documents and interviews with numerous witnesses. The investigation was led by the U.S. Attorney’s Office for the Southern District of New York and the Federal Bureau of Investigation.

The charges against SAC Capital Advisors and its subsidiaries are a significant blow to the company, which has been one of the most successful hedge funds in the industry. The company’s assets under management total over $15 billion, making it one of the largest hedge funds in the world.

The case is U.S. v. SAC Capital Advisors, L.P., et al., 13-cr-00522, U.S. District Court for the Southern District of New York.

SAC Capital Advisors, L.P. is a private investment firm with its principal place of business in Stamford, Connecticut.

The company’s employees who are charged in the indictment include several high-ranking executives, including portfolio managers and analysts. The employees are accused of using non-public information to trade in the securities of several publicly traded companies.

The indictment alleges that the trades were made in the securities of companies such as Elan Pharmaceuticals, Wyeth, and Dell Inc. The trades were made based on inside information that included details about upcoming mergers and acquisitions, product launches, and other corporate events.

The charges against SAC Capital Advisors and its subsidiaries include conspiracy to commit securities fraud, securities fraud, and aiding and abetting securities fraud. The company’s employees also face charges of conspiracy to commit securities fraud and securities fraud.

The case against SAC Capital Advisors and its subsidiaries is the result of a lengthy investigation by the U.S. government, which included a review of millions of documents and interviews with numerous witnesses. The investigation was led by the U.S. Attorney’s Office for the Southern District of New York and the Federal Bureau of Investigation.

SAC Capital Advisors, L.P. is a defendant in this case. The exact amount of the fine will be determined by the court.

MORE FEDERAL CRIME NEWS

White Collar Crime

Sosa Eliosa, Wire Fraud, New Jersey 2015

Jan 15, 2015

White Collar Crime

Jesus Lopez Herrera, Money Laundering, Nevada 1992

Jan 15, 1992

White Collar Crime

Cedeno Garcia, Money Laundering, Florida 2016

Jan 15, 2016

White Collar Crime

Dairyland Power Cooperative, Clean Air Act Violations, Wisconsin 2023

Jun 29, 2012